Paul Chang

446 total citations
10 papers, 66 citations indexed

About

Paul Chang is a scholar working on Genetics, Hematology and Pharmacology. According to data from OpenAlex, Paul Chang has authored 10 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 3 papers in Pharmacology. Recurrent topics in Paul Chang's work include Chronic Lymphocytic Leukemia Research (4 papers), Pain Management and Treatment (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Paul Chang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Pain Management and Treatment (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Paul Chang collaborates with scholars based in United States, United Kingdom and Australia. Paul Chang's co-authors include Vincent Galan, Jeyakumar Subbaroyan, James Scowcroft, Peter S. Staats, Sean Li, Anand Rotte, James B. Bussel, Bruno Musch, Jeffrey S. Wasser and Sean Li and has published in prestigious journals such as Blood, Neurology and Journal of Hepatology.

In The Last Decade

Paul Chang

9 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Chang United States 5 33 27 23 19 13 10 66
Cara Reimer Canada 5 15 0.5× 2 0.1× 26 1.1× 8 0.4× 5 0.4× 9 129
Jaron L. Winston United States 4 15 0.5× 24 0.9× 9 0.4× 7 0.4× 1 0.1× 5 86
Camille Deprouw France 4 13 0.4× 9 0.3× 4 0.2× 3 0.2× 4 0.3× 6 63
Aidan O’Shea Ireland 6 17 0.5× 15 0.6× 14 0.6× 1 0.1× 2 0.2× 7 119
A T Claassen Netherlands 5 61 1.8× 42 1.6× 42 1.8× 4 0.3× 6 145
Anne Freynet France 3 24 0.7× 16 0.6× 11 0.5× 6 0.5× 8 81
Eduardo M. Fraifeld United States 3 6 0.2× 3 0.1× 9 0.4× 2 0.1× 13 1.0× 5 57
Vandana Girotra United Kingdom 4 13 0.4× 8 0.3× 4 0.2× 1 0.1× 27 2.1× 5 71
Jayant Khitha United States 4 6 0.2× 21 0.8× 4 0.2× 3 0.2× 1 0.1× 18 113
Rajendra Kumar Sahoo India 5 17 0.5× 7 0.3× 9 0.4× 2 0.2× 13 57

Countries citing papers authored by Paul Chang

Since Specialization
Citations

This map shows the geographic impact of Paul Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chang more than expected).

Fields of papers citing papers by Paul Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chang. The network helps show where Paul Chang may publish in the future.

Co-authorship network of co-authors of Paul Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Chang. A scholar is included among the top collaborators of Paul Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Chang. Paul Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chung, Joanie, et al.. (2025). Nonselective Beta-Blocker Associated With Decreased Mortality in Patients With Gastric Varices. Gastro Hep Advances. 4(8). 100690–100690.
2.
Galan, Vincent, James Scowcroft, Paul Chang, et al.. (2021). Ten kHz spinal cord stimulation for the treatment of chronic peripheral polyneuropathy: 12‐Month results from prospective open‐label pilot study. Pain Practice. 21(8). 898–906. 10 indexed citations
3.
Galan, Vincent, James Scowcroft, Paul Chang, et al.. (2020). 10-kHz Spinal Cord Stimulation Treatment for Painful Diabetic Neuropathy: Results from Post-Hoc Analysis of the SENZA-PPN Study. Pain Management. 10(5). 291–300. 27 indexed citations
5.
Cloherty, Gavin, Emily K. Butler, Mary C. Kuhns, et al.. (2018). Novel markers predict HBs-antigen seroclearance in chronic hepatitis B patients from the SWAP clinical trial. Journal of Hepatology. 68. S507–S508. 1 indexed citations
6.
Singla, Neil & Paul Chang. (2013). A systematic review of the sensitivity of efficacy endpoints TOTPAR and SPID in acute pain. Journal of Pain. 14(4). S11–S11. 1 indexed citations
7.
Bussel, James B., Francesco Rodeghiero, Roger M. Lyons, et al.. (2011). Sustained Hemostatic Platelet Counts in Adults with Immune Thrombocytopenia (ITP) Following Cessation of Treatment with the TPO Receptor Agonist Romiplostim: Report of 9 Cases,. Blood. 118(21). 3281–3281. 13 indexed citations
8.
Giovannoni, Gavin, Giacomo P. Comi, Peter Rieckmann, et al.. (2009). Results from the CLARITY Study: a Phase III, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Oral Cladribine in Relapsing-Remitting Multiple Sclerosis (RRMS). 6 indexed citations
9.
Bussel, James B., David J. Kuter, Adrian C. Newland, et al.. (2009). Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study.. Blood. 114(22). 681–681. 6 indexed citations
10.
Comi, Giacomo P., Sandra Cook, Gavin Giovannoni, et al.. (2009). MRI outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026